牛唐2018-07-31 16:44
$Surface Oncology(SURF)$ FDA授予治疗多发性骨髓瘤的SRF231孤儿药资格,它是一款靶向CD47的单抗药物,是继$Forty Seven(FTSV)$ 的Hu5F9-G4、$Trillium Therapeutics Inc. (TRIL)$ 的TTI-621之后的第三个靶向CD47的孤儿药查看全文
张小丰2018-06-29 08:11
$Forty Seven(FTSV)$
Data from the Phase 1b Portion of the Ongoing Phase 1b/2 Trial of 5F9 in Combination with Rituximab in r/r NHL
Forty Seven's Phase 1b/2 trial is designed to evaluate 5F9 in combination with rituximab in patients with r/r NHL, including patient...查看全文
JZee2018-06-28 07:51
$Forty Seven(FTSV)$ 定价在IPO价格上端16元。@Stevevai1983 怎么看这个CD 47靶点的创业公司?看创始人名头很大,值得投机一把么?查看全文
$Forty Seven(FTSV)$ 15-12B Securities registration termination [Section 12(b)] Accession Number: 0001104659-20-047951 Act: 34 Size: 20 KB 网页链接
$Forty Seven(FTSV)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902219-20-000371 Act: 34 Size: 33 KB 网页链接
$Forty Seven(FTSV)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000690 Act: 33 Size: 1 KB 网页链接
$Forty Seven(FTSV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023727 Size: 19 KB 网页链接
$Forty Seven(FTSV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023722 Size: 9 KB 网页链接
$Forty Seven(FTSV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023723 Size: 16 KB 网页链接
$Forty Seven(FTSV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023724 Size: 14 KB 网页链接
$Forty Seven(FTSV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023717 Size: 9 KB 网页链接
$Forty Seven(FTSV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023720 Size: 9 KB 网页链接
$Forty Seven(FTSV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023714 Size: 19 KB 网页链接